Tag | Content |
---|
EnhancerAtlas ID | HS095-17780 |
Organism | Homo sapiens |
Tissue/cell | HMEC |
Coordinate | chr2:232484900-232486850 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
SP2 | MA0516.2 | chr2:232486469-232486486 | AGGGGGGCGGGAATGAG | - | 6.09 |
|
| Number of super-enhancer constituents: 30 | ID | Coordinate | Tissue/cell |
SE_00290 | chr2:232484495-232487313 | Adipose_Nuclei | SE_04095 | chr2:232484927-232486880 | Brain_Anterior_Caudate | SE_05971 | chr2:232484760-232486845 | Brain_Hippocampus_Middle | SE_06873 | chr2:232484923-232486934 | Brain_Hippocampus_Middle_150 | SE_08036 | chr2:232484725-232486925 | Brain_Inferior_Temporal_Lobe | SE_24773 | chr2:232485749-232486298 | Colon_Crypt_3 | SE_26538 | chr2:232484795-232486763 | Esophagus | SE_29632 | chr2:232485125-232487095 | Fetal_Muscle | SE_31729 | chr2:232485555-232486474 | Gastric | SE_32897 | chr2:232485087-232486791 | H1 | SE_34336 | chr2:232484441-232487898 | HCT-116 | SE_34676 | chr2:232485428-232486520 | HeLa | SE_40811 | chr2:232484903-232486887 | Left_Ventricle | SE_42307 | chr2:232485093-232486638 | Lung | SE_46935 | chr2:232485589-232486340 | Ovary | SE_48354 | chr2:232485498-232486497 | Psoas_Muscle | SE_48709 | chr2:232485131-232486510 | Right_Atrium | SE_50073 | chr2:232484817-232486499 | Sigmoid_Colon | SE_51303 | chr2:232485073-232486987 | Skeletal_Muscle | SE_52724 | chr2:232485038-232486850 | Small_Intestine | SE_53567 | chr2:232484849-232486856 | Spleen | SE_54713 | chr2:232485195-232486722 | Stomach_Smooth_Muscle | SE_55586 | chr2:232485138-232485445 | Thymus | SE_55586 | chr2:232485856-232486574 | Thymus | SE_56858 | chr2:232485137-232486801 | VACO_400 | SE_58398 | chr2:232468621-232552645 | Ly1 | SE_61093 | chr2:232461681-232552859 | HBL1 | SE_61422 | chr2:232466061-232552901 | Toledo | SE_65563 | chr2:232485719-232487644 | Pancreatic_islets | SE_68881 | chr2:232485117-232486757 | H9 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I231619 | chr2 | 232484398 | 232487584 |
|
Enhancer Sequence | GTAGGGGCTG GACCACCTGC AATTCAAGAG TCCTCCTCAT GCTGATTCCT TTGGGTCTGA 60 CCTCCTGCCA CATCACACCC TCCTGCTTGT TGCCCTCCTC CTGGACTGCC CTTCCTTCTC 120 TGCCCATTGC CTCCTACATT CCAAAGACCA GCTGGGACCT GTCATTCCTT CTTCAAAGCC 180 TTTAATTCCC AAGCAGAATT ACCTGCTTTC TCCCTGAACT CCCAGATCAC TGTTATCAAA 240 GACATAACAT TGTATTATTC ATTTGTCACT GTTTTTATTG AGCATCTGCT AAATGCTGGG 300 CCTCCTGTTA GGTGCAAGAG ACACAGTCAC AAATGCAGCA CAGGGCTGTC CTTGGGGGCC 360 TACAGCCTGT GGCACCGTGG TCATGGCCCC ATCCTTTCCT CCATATAGGG CCTGTCCTCT 420 CTTTGCAACC TTGGAGCTAG CGTGACACAC AGCAGCCTCG AGTCTCAGCA TTTGTGAAAT 480 GAATGATTGA GGCTGTGCAG ACCTTTCTCT GCTAGCTCAC AAGCAGTTGC TGCCTTCCTG 540 AGAGGCTTTG GAGAAAGTGC TAGCTTAAAA TATGTCCCCA AGTAGCTGAA TCTGTAGGAT 600 ATCATGATTC TGTGGTGTCC ACGTGAACTC AACATTCAAC CTGTCGAGAG CAAAAGTCAG 660 CAGAAACTGA CTTCGTTTCC CTGTTATTGA TATGAGGCTG TGGGGGCTCA CTGTAATTAA 720 TCAGTAGGGT CAGCCGCCTT TGAAGGTTAC TCGTTGTTCC TCATAGCGGC ATCTCCGCAG 780 TATGGATGGA GATGCGGAAC ATCCCGTGGC AGTCATCAGA AATTTATGCG TCTAATTGAT 840 CTGAAAACTG AAGGAATTTA GCAACAAGTT AAGACGGAAG GCGACCAAGG TGTGGCCCTA 900 TTAGCTTTGT TGCTCAGCAC ATAGCCCCAG GCATTTACAG GAGGGGCCAC ACAAGTCCTT 960 TGTCACTAGT CCTTTGTCAC TAGCGGCAGC CTCACCTGAG AAGACCTCCA AGGGTGCTGC 1020 CTGTACCGTC AGGAGGTGGG GAGTGTCCGA GGGCCCTGGA GTGCACAGAT CCGCCCTGGA 1080 GGGTAGCCAT GGGGACAGCC CACTCCATCC TCCCACCCCT ACCCCGACTT CCTGGCCTTC 1140 CCAGGCAAAT GTAGGCCACC TTGTGTTCAG TTTCCTGGAG AGTCTCCTTT CCCCAGCATC 1200 CGGGTCCCCA GGGGAGGGGT GACAGCTACC CCTGTCCCCG ATCTGTGGGG CCTGGCCGCC 1260 TTCCGCAGGG CTGCGCGCCA TTCCCGCATC GTGCTGCGTC TTGGATGATT TTCCTGGCTG 1320 TGACCCAAGC ACCTGGAGCC TCCATTATCT GTGCTCAGAA TTTCCAAGTC TCTCCAAAGT 1380 CCTCCAAGGA GAACCCCCGC CCCACCCCCA GACACTGATG CGGGCCTCCA AGAGTTTGTT 1440 TTTTTGTTTT TTGTGGGTTT TTTTTTTTGC AGTGTGACAA GGTTCCTGGA AACCACGGGA 1500 GTTTTACTAC ATTCCCTGGG ACTTGTTTAC CGGAGATGCA GATTGCAGCG GCGGTGGGTG 1560 CGGGGGATGA GGGGGGCGGG AATGAGCCTT CTCCCCAGAG CTGGGGAACC TGTTTCTGTT 1620 TCTGTTTCAT CATTGTCTGG TCTGTCCTCG TTGCCTCTTA GGCAGAGCTG ATGCCCCATT 1680 ATAATCTAAG CTGCAGGAGA AATGGTCTCA GAAATGGGCT CAAAACACTG CCCCTGGATC 1740 CCATAATCTA AAATTTAAAA TATTCCGTGA AGCATGCCCC TTGTATCATA TCAGCTCTCC 1800 TCTTCCCTCT GTCCTCCTTA AACCTGCACC ATTTTTGGTG TCCTCTCTCT CTCTCTCTTT 1860 TTTTTTTTTT TTTTTGTTGT TGTTGTTGTT GAGACAGAGT CTCGCACTGT CGCCCAGGCT 1920 GGAGTGCAGT GGCGTGATCT CGGCTCACTG 1950
|